Evidence of an increased incidence of day 3 parasitaemia in Suriname: An indicator of the emerging resistance of Plasmodium falciparum to artemether

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 8, 2013, Pages 968-973

  Vreden, Stephen G S ^a   Jitan, Jeetendra K ^b   Bansie, Rakesh D ^c   Adhin, Malti R ^d  

^a Suriname Forest Service   (Suriname)

^b Ministry of Health   (Suriname)

^c ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

^d ANTON DE KOM UNIVERSITY OF SURINAME   (Suriname)

Author keywords

Artemether; Artemisinin resistance; Day 3 parasitaemia; Plasmodium falciparum; Suriname

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADOLESCENT; ADULT; CHILD; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; INCIDENCE; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SURINAME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; SURINAME; YOUNG ADULT;

EID: 84890319200     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276130167     Document Type: Article

References (31)

1. ABS-General Bureau of Statistics 2005. 7th General population and housing census in Suriname. Available from: statistics-suriname. org.
2. Adhin MR, Labadie-Bracho M, Vreden S 2012. Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname. Malar J 11: 322.
3. Aponte SL, Díaz G, Pava Z, Echeverry DF, Ibarguen D, Rios M, Murcia LM, Quelal C, Murillo C, Gil P, Björkman A, Osorio L 2011. Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept. Mem Inst Oswaldo Cruz 106 (Suppl. I): 123-129.
4. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, Darapiseth S, Teja-Isavadharm P, Khemawoot P, Schaecher K, Ruttvisutinunt W, Lin J, Kuntawungin W, Gosi P, Timmermans A, Smith B, Socheat D, Fukuda MM 2011. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS ONE 6: e19283.
5. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, Frühauf H, Schaub B, Pfeil J, Peshu J, Hanpithakpong W, Rippert A, Juma E, Tsofa B, Mosobo M, Lowe B, Osier F, Fegan G, Lindegårdh N, Nzila A, Peshu N, Mackinnon M, Marsh K 2011. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS ONE 6: e26005.
6. Cheeseman I, Miller B, Nair Sh, Nkhoma S, Tan A, Tan J, Saai S, Phyo A, Moo C, Lwin K, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp A, Mayxay M, Newton P, White N, Nosten F, Ferdig M, Anderson T 2012. A major genome region underlying artemisinin resistance in malaria. Science 336: 79-82.
7. Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Breman JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV 2011. The threat of artemisinin-resistant malaria. N Engl J Med 365: 1073-1075.
8. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
9. Evans III L, Coignez V, Barajos A, Bempong D, Bradby S, Dijiba Y, James M, Bretas G, Adhin M, Ceron N, Hinds-Semple A, Chibwe K, Lukulay P, Pribluda V 2012. Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname. Malar J 11: 203.
10. Flegg J, Guerin P, White N, Stepniewska K 2011. Standardizing the measurement of parasite clearance in falciparum malaria; the parasite clearance estimator. Malar J 10: 339.
11. Gama BE, Lacerda MVG, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2011. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control. Mem Inst Oswaldo Cruz 106 (Suppl. I): 159-166.
12. Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM 2011. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. Mem Inst Oswaldo Cruz 106: 685-690.
13. Heemskerk M 2009. Kleinschalige goudwinning in Suriname-Een overzicht van sociaaleconomische, politieke en milieu-aspecten, Centrum voor Studie en Documentatie van Latijns Amerika Para-maribo, Amsterdam, Netherlands, 39 pp.
14. Hiwat H, Hardjopawiro LS, Takken W, Villegas L 2012. Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J 11: 10.
15. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O 2005. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfAT Pase6. Lancet 366: 1960-1963.
16. Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M 2008. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med 359: 2619-2620.
17. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Moo CI, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379: 1960-1966.
18. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick S 2003. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother 47: 2418-2423.
19. Pillai DR, Lau R, Khainar K, Lepore R, Via A, Staines HM, Krishna S 2012. Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Malar J 11: 131.
20. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NPJ, de Vries PJ, Dorsey G, Guthmann J, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WRJ, Nosten F, White NJ 2010. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 201: 570-579.
21. Veiga MM 1997. Artisanal gold mining activities in Suriname, United Nations Industrial Development Organization, Vancouver, 31 pp.
22. Vreden SGS, Jitan JK, Eersel MGM, Keenswijk WG, Danson, Bretas G, Ruebush TK 2011. Antimalarial efficacy in Suriname 2001-2006: implications of evidence-based therapy change. Available from: usaidami. org/extras/vreden1. pdf.
23. White N 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41: 1413-1422.
24. White NJ 2011. The parasite clearance curve. Malar J 10: 278.
25. WHO-World Health Organization 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria, WHO, Geneve, 68 pp.
26. WHO-World Health Organization 2009. Methods for surveillance of antimalarial drug efficacy, WHO, Geneve, 90 pp.
27. WHO-World Health Organization 2010a. Global report on antimalarial efficacy and drug resistance: 2000-2010. Available from: who. int/malaria/publications/atoz/9789241500470/en/.
28. WHO-World Health Organization 2010b. World malaria report 2010. Available from: who. int/malaria/world_malaria_report_2010/en/.
29. WHO-World Health Organization 2010c. Procurement of artemether-lumefantrine (Coartem®) through WHO. Available from: archives. who. int/tbs/access/CoA_website5. pdf.
30. WHO-World Health Organization 2011. Global plan for artemisinin resistance containment (GPARC). Available from: who. int/malaria/publications/atoz/9789241500838/en/.
31. WHO-World Health Organization 2012. Update on artemisinin resistance-April 2012. Available from: who. int/malaria/publications/atoz/arupdate042012. pdf.